Stryker Corporation (SYK) Current Ratio: 1.89
Is Stryker Corporation’s current ratio high or low?
Stryker Corporation's current ratio of 1.89 is in line with its 5-year average of 1.86, around the middle of its 5-year range (1.58–2.20).
As of Wednesday, June 17, 2026. 1.56% below its 12-month average of 1.92.
SYK Current Ratio Chart
SYK Average Current Ratio Chart
SYK Current vs Average Current Ratio Chart
SYK Current Ratio Metrics
CURRENT RATIO
1.89
CURRENT RATIO AVG TTM
1.92
CURRENT RATIO AVG 3Y
1.76
CURRENT RATIO AVG 5Y
1.86
CURRENT RATIO AVG 10Y
2.19
CURRENT RATIO AVG 15Y
2.66
CURRENT RATIO AVG 20Y
2.79
CURRENT VS TTM AVG
-1.56%
CURRENT VS 3Y AVG
+7.23%
CURRENT VS 5Y AVG
+1.43%
CURRENT VS 10Y AVG
-13.81%
CURRENT VS 15Y AVG
-28.86%
CURRENT VS 20Y AVG
-32.25%
SYK Competitors' Current Ratio
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stryker Corporation (SYK) | $119.06B | 1.89 | 1.92 | 1.76 | 1.86 |
| Bristol-Myers Squibb Company (BMY)vs › | $114.38B | 1.26 | 1.25 | 1.30 | 1.38 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $113.82B | 2.90 | 2.79 | 3.60 | 3.87 |
| CVS Health Corporation (CVS)vs › | $127.54B | 0.84 | 0.82 | 0.86 | 0.88 |
| Danaher Corporation (DHR)vs › | $128.72B | 1.87 | 1.64 | 1.71 | 1.69 |
| Medtronic plc (MDT)vs › | $104.05B | 0.00 | 1.94 | 2.03 | 2.16 |
| Intuitive Surgical, Inc. (ISRG)vs › | $148.26B | 4.87 | 4.47 | 4.53 | 5.01 |
| Pfizer Inc. (PFE)vs › | $148.76B | 1.16 | 1.17 | 1.11 | 1.20 |
| HCA Healthcare, Inc. (HCA)vs › | $88.05B | 0.83 | 0.96 | 1.12 | 1.22 |
| Elevance Health Inc. (ELV)vs › | $86.74B | 1.24 | 1.17 | 1.08 | 1.07 |
Liquidity Analysis
Current Ratio
1.89
Quick Ratio
1.21
Stryker Corporation Current Ratio Formula & Definition
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Stryker Corporation Current Ratio FAQ
- What is the current ratio for Stryker Corporation (SYK)?
- The current ratio for SYK stock is 1.89.
- Is Stryker Corporation's current ratio high or low?
- Stryker Corporation's current ratio of 1.89 is in line with its 5-year average of 1.86, around the middle of its 5-year range (1.58–2.20).
- What is the TTM average current ratio for Stryker Corporation (SYK)?
- The TTM average current ratio for SYK stock is 1.92.
- What is the 3Y average current ratio for Stryker Corporation (SYK)?
- The 3Y average current ratio for SYK stock is 1.76.
- What is the 5Y average current ratio for Stryker Corporation (SYK)?
- The 5Y average current ratio for SYK stock is 1.86.
- What is the 10Y average current ratio for Stryker Corporation (SYK)?
- The 10Y average current ratio for SYK stock is 2.19.
- What is the 15Y average current ratio for Stryker Corporation (SYK)?
- The 15Y average current ratio for SYK stock is 2.66.
- What is the 20Y average current ratio for Stryker Corporation (SYK)?
- The 20Y average current ratio for SYK stock is 2.79.
Stryker Corporation Current Ratio History
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 1.89 |
| 2024-12-31 | 1.95 |
| 2023-12-31 | 1.58 |
| 2022-12-31 | 1.63 |
| 2021-12-31 | 2.20 |
| 2020-12-31 | 1.93 |
| 2019-12-31 | 2.58 |
| 2018-12-31 | 2.02 |
| 2017-12-31 | 2.43 |
| 2016-12-31 | 3.08 |
| 2015-12-31 | 2.83 |
| 2014-12-31 | 2.17 |
| 2013-12-31 | 3.14 |
| 2012-12-31 | 4.42 |
| 2011-12-31 | 3.93 |
| 2010-12-31 | 4.73 |
| 2009-12-31 | 4.06 |
| 2008-12-31 | 3.41 |
| 2007-12-31 | 3.68 |
| 2006-12-31 | 2.62 |
| 2005-12-31 | 2.30 |
| 2004-12-31 | 1.92 |
| 2003-12-31 | 1.64 |
| 2002-12-31 | 1.63 |
| 2001-12-31 | 1.86 |
| 2000-12-31 | 1.61 |
| 1999-12-31 | 1.66 |
| 1998-12-31 | 1.88 |
| 1997-12-31 | 2.50 |
| 1996-12-31 | 2.99 |
Related Metrics
About Stryker Corporation
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kevin A. Lobo